ABOUT INTARCIA

Intarcia Therapeutics, Inc., is a rapidly emerging biopharmaceutical company committed to developing therapies with the potential to transform therapeutic categories. By focusing our efforts on serious diseases that are poorly controlled, we leverage our drug delivery technology platform to optimize patient adherence with treatment while improving convenience and tolerability of these therapies.

At Intarcia, we foster an entrepreneurial environment for our carefully chosen talent, and work closely with key thought leaders and clinical investigators from academic centers of excellence. We are proud of our people and the culture of our company, and consistently strive to uphold our core values and our ethical integrity in everything we do.

We have a very active and intense business development effort to seek partners to share the possibilities of our unique technology platform by bringing new and transformational products to other therapeutic areas. Our technology holds broad potential applications with pharmaceutical and biotechnology companies that have therapies in disease areas where poor patient tolerance to therapy and non-optimized treatment regimens represent significant obstacles to achieving treatment success. We are currently seeking a worldwide partner

Our drug development expertise is a key competitive advantage, and is demonstrated by our ability to stabilize therapeutic proteins and peptides and to deliver them in a constant and consistent manner over an extended period of time via the unique and proprietary DUROS® drug delivery platform. For more information about our technology, see the Products & Technology section of this website.

Our most advanced product is ITCA 650 in Type 2 Diabetes (T2D). Currently planned to begin Phase 3 clinical study later this year, the therapy holds significant promise as a ‘game-changing’ treatment in this increasingly common and important disease. Further information about ITCA 650 is also available in the Products & Technology section of this website.

Intarcia is privately held with its headquarters and manufacturing facilities in Hayward, CA.